Pattern of some risk factors for cardiovascular disease in untreated Nigerian hypertensive patients

West African Journal of Medicine

Volumn 25, Issue 3, 2006, Pages 190-194

  Oghagbon, E K ^a   Okesina, A B ^b  

^a DELTA STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Coronary heart disease; Hypertension; Nigeria; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; NIGERIA; OBESITY; PRESCRIPTION; PREVALENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; NIGERIA; RISK FACTORS;

EID: 33846105310     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bouromur J, Ekoba J. Le Cardiopathies Ischaemique en Republic poulex du Congo Etude de premiers les observes. Tropical Cardiology. 1980; 6: 21-25
2. Hutchinson RG, Watson RL, Davis CE, Barnes R, Brown S, Romm F et al. Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis risk in communities. Angiology. 1997; 48: 279-290
3. Kadiri S, Salako BL. Cardiovascular risk factors in middle aged Nigerians. East African Med J. 1997; 5: 303-306
4. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd K. Is abdominal fat distribution a major explanation for the sex difference I the incidence of myocardial infarction. Am J Epidemiol. 1992; 135: 266-273
5. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi. M et al. Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985; 75: 809-817
6. Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004; 110: e7-e12
7. Watkins LO, Neaton JD, Kuller LH. Racial differences in high density lipoprotein cholesterol and coronary heart disease incidence in the usual care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1986; 57: 538-545
8. Jarikre AE, Dim DC, Ajuluchukwu JNA. Plasma lipid levels in Nigerian hypertensives: the gender factor. Nig Qt J Hosp Med. 1996; 6: 293-298
9. Adedeji OO, Onitiri AC. Plasma lipids in Nigerian hypertensives. Afr J Med med Sci. 1990; 19: 281-284
10. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J med. 1996; 334: 374-381
11. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499
12. Kadiri S, Walker O, Salako BL, Akinkugbe O. Blood pressure, hypertension and correlates in urbanized workers in Ibadan, Nigeria: a revisit. J Hum Hypertens. 1999; 13: 744-752
13. Nirmala A. Age variation in blood pressure: effect of sex and urbanization in a genetically homogenous caste population of Andra Pradesh. Am J Human Biol. 2001; 13: 744-752
14. Gupta R, Guptha S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in West India. J Hypertens. 1995; 13: 1193-1200
15. Agboola-Abu CF, Onabolu A. Plasma lipid levels in patients attending Igbinedion Hospital and Medical Research Centre, Okada, Edo State, Nigeria. NJM. 2000; 38: 1-5
16. Papadakis JA, Ganotakis ES, Jarrod IA, Mikhailidis Dp, Winder AF. Effect of hypertension and its treatment on lipids, lipoprotein(a), fibrinogen and bilirubin levels in patients referred for hyperlipidaemia. Am J Hypertens. 1991; 12: 673-681
17. Meade TW, North WRS, Chakrabarti R. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980; 1: 1050-1054
18. Castelli WP. The Triglyceride issue: a view from Framingham. Am Heart J. 1996; 112: 432-437
19. Manninen V, Tenkanen L, Koskinen P. Joint effects of serum triglyceride and LDL-Cholesterol and HDL-Cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation. 1992; 85: 37-45
20. Taylor GO, Agbedana PO. A comparative study of plasma high density lipoprotein in two groups of Nigerians of different socioeconomic status. Afr J Med med Sci. 1983; 12: 23-28
21. Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum hypertens. 2000; 14: 83-90
22. Toft I, Bonaa KH, Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension. 1998; 32: 115-122
23. Landray MJ, Edmunds E, Li-Saw-Hee FL, Hughes BA, Beevers DG, Kendall MJ et al. Abnormal low density lipoprotein subfraction profile in patients with untreated hypertension. Q J Med. 2002; 95: 165-171
24. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993; 119: 655-660
25. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk and coronary mortality. 15-year follow-up of middle aged men and women in Eastern Finland. Circulation. 1996; 93: 1372-1379
26. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985; 103: 983-988
27. Shaper AG, Wannamethee SG, Walker M. Body weight: implications for the prevention of coronary heart disease, stroke and diabetes mellitus in a cohort study of middle age men. BMJ. 1997; 314: 1311-1315
28. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States. 1988-2000. JAMA. 2003; 1290: 199-206